BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3555041)

  • 1. Systemic treatment of cutaneous infections. A comparative study of ciprofloxacin and cefotaxime.
    Parish LC; Asper R
    Am J Med; 1987 Apr; 82(4A):227-9. PubMed ID: 3555041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative, double-blind study of oral ciprofloxacin and intravenous cefotaxime in skin and skin structure infections.
    Ramirez-Ronda CH; Saavedra S; Rivera-Vázquez CR
    Am J Med; 1987 Apr; 82(4A):220-3. PubMed ID: 3555040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections.
    Pérez-Ruvalcaba JA; Quintero-Pérez NP; Morales-Reyes JJ; Huitrón-Ramírez JA; Rodríguez-Chagollán JJ; Rodríguez-Noriega E
    Am J Med; 1987 Apr; 82(4A):242-6. PubMed ID: 3555042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral ciprofloxacin vs parenteral cefotaxime in the treatment of difficult skin and skin structure infections. A multicenter trial.
    Gentry LO; Ramirez-Ronda CH; Rodriguez-Noriega E; Thadepalli H; del Rosal PL; Ramirez C
    Arch Intern Med; 1989 Nov; 149(11):2579-83. PubMed ID: 2684078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative evaluation of oral ofloxacin versus intravenous cefotaxime therapy for serious skin and skin structure infections.
    Gentry LO; Rodriguez-Gomez G; Zeluff BJ; Khoshdel A; Price M
    Am J Med; 1989 Dec; 87(6C):57S-60S. PubMed ID: 2690621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of intravenous ciprofloxacin in difficult-to-treat infections.
    Giamarellou H; Galanakis N
    Am J Med; 1987 Apr; 82(4A):346-51. PubMed ID: 3555059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis.
    Tuncer I; Topcu N; Durmus A; Turkdogan MK
    Hepatogastroenterology; 2003; 50(53):1426-30. PubMed ID: 14571754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciprofloxacin: an update on clinical experience.
    Arcieri G; Griffith E; Gruenwaldt G; Heyd A; O'Brien B; Becker N; August R
    Am J Med; 1987 Apr; 82(4A):381-6. PubMed ID: 3555063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin versus cefotaxime in skin and skin structure infections: a double-blind study.
    Ramirez-Ronda C; Saavedra S
    Chemioterapia; 1987 Jun; 6(2 Suppl):432-4. PubMed ID: 3334591
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of intravenous ciprofloxacin and intravenous cefotaxime for antimicrobial prophylaxis in transurethral surgery.
    Cox CE
    Am J Med; 1989 Nov; 87(5A):252S-254S. PubMed ID: 2686427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose oral ciprofloxacin compared with cefotaxime and placebo for prophylaxis during transurethral surgery.
    Klimberg IW; Malek GH; Cox CE; Patterson AL; Whalen E; Kowalsky SF; Echols RM
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():77-84. PubMed ID: 10225576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftizoxime vs. cefotaxime--a comparative randomized multicenter study.
    Segev S; Kitzes R; Rubinstein E; Pitlik S; Samra Y; Shenkman L; Weinberg M
    Isr J Med Sci; 1988 Aug; 24(8):410-4. PubMed ID: 3045049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral ciprofloxacin in the treatment of serious soft tissue and bone infections. Efficacy, safety, and pharmacokinetics.
    Nix DE; Cumbo TJ; Kuritzky P; DeVito JM; Schentag JJ
    Am J Med; 1987 Apr; 82(4A):146-53. PubMed ID: 3555029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential intravenous/oral ciprofloxacin as an empiric antimicrobial therapy: results of a Canadian multicenter study. The Canadian Collaborative Investigational Group.
    Davis C
    Clin Ther; 1994; 16(3):505-21. PubMed ID: 7923317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea.
    Pichler HE; Diridl G; Stickler K; Wolf D
    Am J Med; 1987 Apr; 82(4A):329-32. PubMed ID: 3555057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ciprofloxacin treatment in bacterial skin infections].
    Mohr CP; Küchmeister B; Reinel D; Ulrich R
    Fortschr Med; 1989 May; 107(16):367-9. PubMed ID: 2737587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of ciprofloxacin compared with other antimicrobial therapy in the treatment of osteomyelitis.
    Greenberg RN; Tice AD; Marsh PK; Craven PC; Reilly PM; Bollinger M; Weinandt WJ
    Am J Med; 1987 Apr; 82(4A):266-9. PubMed ID: 3555046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciprofloxacin versus cinoxacin in therapy of urinary tract infections. A randomized, double-blind trial.
    Goldstein EJ; Kahn RM; Alpert ML; Ginsberg BP; Greenway FL; Citron DM
    Am J Med; 1987 Apr; 82(4A):284-7. PubMed ID: 3555049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of ciprofloxacin in the treatment of patients with respiratory tract infections in Japan.
    Kobayashi H
    Am J Med; 1987 Apr; 82(4A):169-73. PubMed ID: 3555031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected].
    Iravani A; Tice AD; McCarty J; Sikes DH; Nolen T; Gallis HA; Whalen EP; Tosiello RL; Heyd A; Kowalsky SF
    Arch Intern Med; 1995 Mar; 155(5):485-94. PubMed ID: 7864704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.